MCH buys gelatine capsule producer HC Clover

As part of the deal, the management team will continue to lead the business and will retain a minority stake, while the GP will own an undisclosed stake, described as "significant".

Following the transaction, the company aims to use the capital injection to boost its geographical expansion across new markets, develop new products and duplicate its current production capacity through the opening of a new industrial facility.

The deal marks the third transaction for the GP's MCH Iberian Capital Fund IV vehicle, which recently held a first close on €200m in June 2016. In February 2016, the fund acquired a 35% stake in Jeanologia, a Spanish business operating in the textile industry, for €10m. In April, it bought a minority stake in Brasmar, a Portuguese processor and distributor of frozen fish products.

Company
Established in 2007 and headquartered in Madrid, HC Clover designs and manufactures soft gelatine capsules for the pharmaceutical, nutritional and beauty and care sectors. The business is active across the South American and southern European market.

The company also has a presence in Portugal and claims to export 30% of its production.

People
MCH Private Equity – José María Muñoz, Jaime Hernández Soto (founding partners).
HC Clover – José Luis Martin Guinea (CEO).

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Send to  

• Topics
• Expansion
• Industrials
• Southern Europe
• Spain